Evidence-Based Medicine Guidelines
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tafenoquine for Preventing Relapse in People With Plasmodium Vivax Malaria." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305333/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria.
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305333/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria. Accessed October 13, 2024.
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305333/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria
Tafenoquine for Preventing Relapse in People With Plasmodium Vivax Malaria [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305333/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
ID - 1305333
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305333/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
